• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗中性粒细胞胞浆抗体相关性血管炎对澳大利亚人群就业和工作残疾的影响。

The impact of antineutrophil cytoplasmic antibody-associated vasculitis on employment and work disability in an Australian population.

机构信息

Department of Nephrology, Monash Health, Monash Medical Centre, Melbourne, Vic., Australia.

Department of Medicine, Monash University, Melbourne, Vic., Australia.

出版信息

Int J Rheum Dis. 2021 Jul;24(7):904-911. doi: 10.1111/1756-185X.14131. Epub 2021 May 21.

DOI:10.1111/1756-185X.14131
PMID:34019342
Abstract

AIM

Although antineutrophil cytoplasmic antibody-associated vasculitis (AAV) most commonly affects older individuals, many patients develop the disease during their most productive working years. The aim of this study was to examine the effects of AAV on employment and work disability in a cohort of Australian patients of working age.

METHODS

Patients attending a vasculitis clinic located in Melbourne, Australia, completed an employment questionnaire in addition to the Work Productivity and Activity Impairment Questionnaire: Specific Health Problem.

RESULTS

The average age of the 47 respondents was 47.8 ± 11.9 years (range 22-63 years), with a median disease duration of 60 months (range 10.2-318.5 months). There were 68.1% who were currently employed, but 20.6% of respondents employed at the time of diagnosis were no longer working and 10.6% had experienced a significant reduction in work hours since their diagnosis. There were 12.7% who were dependent on the disability support pension. The rate of work disability was 23.4%. Many participants considered themselves work impaired (41.9%), with 10.1% having missed work in the previous week. Furthermore, 44.7% of respondents reported that their financial stability had been negatively impacted by their vasculitis diagnosis. Fatigue was commonly reported. Work disabled patients were significantly more likely to be obese and less likely to have completed a tertiary education. Work disabled patients tended to be older, myeloperoxidase-antineutrophil cytoplasmic antibody positive, and have renal involvement and lung involvement.

CONCLUSION

A proportion of people living with AAV in Australia experience a decline in employment and an increase in work disability when living with this condition.

摘要

目的

尽管抗中性粒细胞胞浆抗体相关性血管炎(AAV)最常影响老年人,但许多患者在其最具生产力的工作年龄阶段发病。本研究旨在调查 AAV 对澳大利亚工作年龄患者队列的就业和工作残疾的影响。

方法

在澳大利亚墨尔本的血管炎诊所就诊的患者除了填写工作生产力和活动障碍问卷:特定健康问题外,还完成了一份就业调查问卷。

结果

47 名应答者的平均年龄为 47.8±11.9 岁(范围 22-63 岁),中位疾病病程为 60 个月(范围 10.2-318.5 个月)。目前有 68.1%的人就业,但在诊断时就业的 20.6%的应答者不再工作,10.6%的人自诊断以来工作时间显著减少。有 12.7%的人依赖残疾支持养恤金。工作残疾率为 23.4%。许多参与者认为自己工作能力受损(41.9%),过去一周有 10.1%的人缺勤。此外,44.7%的应答者报告称,血管炎诊断对他们的财务稳定产生了负面影响。疲劳是常见的报告症状。工作残疾患者肥胖的可能性明显更高,而完成高等教育的可能性较低。工作残疾患者往往年龄较大,髓过氧化物酶-抗中性粒细胞胞浆抗体阳性,且有肾脏和肺部受累。

结论

在澳大利亚,一部分患有 AAV 的人在患病期间就业下降,工作残疾增加。

相似文献

1
The impact of antineutrophil cytoplasmic antibody-associated vasculitis on employment and work disability in an Australian population.抗中性粒细胞胞浆抗体相关性血管炎对澳大利亚人群就业和工作残疾的影响。
Int J Rheum Dis. 2021 Jul;24(7):904-911. doi: 10.1111/1756-185X.14131. Epub 2021 May 21.
2
Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎的工作残疾标志物。
Rheumatology (Oxford). 2014 May;53(5):953-6. doi: 10.1093/rheumatology/ket483. Epub 2014 Jan 31.
3
Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study.抗中性粒细胞胞浆抗体相关性血管炎患者的就业、工作残疾与生活质量。EXPOVAS研究
Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):40-46. Epub 2016 Dec 20.
4
Patient and physician perspectives on the impact of health-related quality of life in Mexican patients with ANCA-associated vasculitis.患者和医生对健康相关生活质量在墨西哥抗中性粒细胞胞浆抗体相关性血管炎患者中的影响的看法。
Rheumatol Int. 2018 Apr;38(4):631-640. doi: 10.1007/s00296-017-3904-1. Epub 2017 Dec 15.
5
Assessment of work limitations and disability in systemic vasculitis.系统性血管炎工作限制与残疾的评估
Clin Exp Rheumatol. 2016 May-Jun;34(3 Suppl 97):S111-4. Epub 2016 May 24.
6
Clinical characteristics of patients with vasculitis positive for anti-neutrophil cytoplasmic antibody targeting both proteinase 3 and myeloperoxidase: a retrospective study.抗中性粒细胞胞质抗体(针对蛋白酶 3 和髓过氧化物酶)阳性血管炎患者的临床特征:一项回顾性研究。
Rheumatol Int. 2019 Nov;39(11):1919-1926. doi: 10.1007/s00296-019-04447-w. Epub 2019 Sep 24.
7
Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.抗中性粒细胞胞浆抗体(ANCA)和抗肾小球基底膜抗体双重阳性可预测抗中性粒细胞胞浆抗体相关性血管炎的终末期肾病:一项单中心的初步研究。
Clin Rheumatol. 2020 Mar;39(3):831-840. doi: 10.1007/s10067-019-04854-1. Epub 2019 Dec 4.
8
Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.日本耳科学会提出的抗中性粒细胞胞浆抗体(ANCA)相关性血管炎(OMAAV)性中耳炎的临床特征、诊断标准和治疗建议。
Auris Nasus Larynx. 2021 Feb;48(1):2-14. doi: 10.1016/j.anl.2020.07.004. Epub 2020 Aug 5.
9
[A preliminary study of the significance of autoantibodies against light chain of myeloperoxidase on pulmonary damages in myeloperoxidase-antineutrophil cytoplasmic antibody associated vasculitis].抗髓过氧化物酶轻链自身抗体在髓过氧化物酶-抗中性粒细胞胞浆抗体相关性血管炎肺损伤中意义的初步研究
Zhonghua Nei Ke Za Zhi. 2015 Jun;54(6):511-6.
10
Employment and absenteeism in working-age persons with multiple sclerosis.多发性硬化症患者工作年龄段的就业与缺勤情况。
J Med Econ. 2017 May;20(5):493-502. doi: 10.1080/13696998.2016.1277229. Epub 2017 Jan 25.

引用本文的文献

1
Relationships between patient and physician global assessments in anti-neutrophil cytoplasmic antibody-associated vasculitis.抗中性粒细胞胞浆抗体相关性血管炎中患者与医生整体评估之间的关系。
Clin Rheumatol. 2025 Jan;44(1):367-375. doi: 10.1007/s10067-024-07256-0. Epub 2024 Dec 13.
2
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire.抗中性粒细胞胞浆抗体相关血管炎患者报告结局(AAV-PRO)问卷意大利语版本的验证
Rheumatol Adv Pract. 2024 Jan 22;8(1):rkae001. doi: 10.1093/rap/rkae001. eCollection 2024.
3
How is the patient perspective captured in ANCA-associated vasculitis research? An integrative review.
在抗中性粒细胞胞浆抗体相关性血管炎研究中如何体现患者视角?一项综合综述。
Rheumatol Adv Pract. 2023 Oct 24;7(3):rkad092. doi: 10.1093/rap/rkad092. eCollection 2023.
4
Unmet needs in ANCA-associated vasculitis: Physicians' and patients' perspectives.未满足的需求在抗中性粒细胞胞浆抗体相关性血管炎:医生和患者的观点。
Front Immunol. 2023 Feb 23;14:1112899. doi: 10.3389/fimmu.2023.1112899. eCollection 2023.